Literature DB >> 17065943

The associated effects of untreated unilateral hip dislocation in cerebral palsy scoliosis.

Hakan Senaran1, Suken A Shah, Joseph J Glutting, Kirk W Dabney, Freeman Miller.   

Abstract

INTRODUCTION: The presence of a unilateral hip dislocation in children with cerebral palsy (CP) may cause problems with sitting imbalance, pressure ulcers, and hip pain. There is a dynamic interplay between hip dislocation, pelvic obliquity (PO), and scoliosis. The effect of an untreated unilateral hip dislocation on the rate of curve progression of CP scoliosis has not been defined in the literature. The purpose of this study is to investigate the effect of unilateral hip dislocation on PO and the rate of curve progression in children with spastic quadriplegic CP.
METHODS: Patients with spastic quadriplegic CP who had spine radiographs at the time of initial presentation with scoliosis and at the latest follow-up were evaluated. Twenty-three children with spastic CP who had an untreated unilateral hip dislocation and scoliosis constituted the study group. The control group consisted of 83 quadriplegic CP patients with scoliosis and well-located hips. The rate of curve progression, incidence of PO, and the rate of PO progression at follow-up were compared between the 2 groups.
RESULTS: The mean ages of patients with a unilateral dislocation and with well-located hips at initial radiograph were 10.4 and 10.5 years, respectively. The mean follow-up was 3.5 years. The mean rate of scoliosis curve progression in patients with a unilateral hip dislocation was 12.9 degrees per year. In the control group, the mean progression rate was 12.2 degrees per year. The incidence of PO at follow-up was 74% in scoliotic patients with a dislocation and 63% in scoliotic patients with normal hips. Using repeated-measures analysis of variance, unilateral hip dislocation was found to have no significant effect on scoliosis progression; however, progression of PO was significantly increased in the hip dislocation group (P < 0.05). Pelvic obliquity was corrected after posterior spinal fusion to the sacrum with pelvic fixation, without reducing the hip(s) at the same surgery.
CONCLUSION: Unilateral hip dislocation causes a significant increase of PO but does not affect the rate of scoliosis curve progression.

Entities:  

Mesh:

Year:  2006        PMID: 17065943     DOI: 10.1097/01.bpo.0000242426.60995.29

Source DB:  PubMed          Journal:  J Pediatr Orthop        ISSN: 0271-6798            Impact factor:   2.324


  6 in total

Review 1.  Surgical advances in the treatment of neuromuscular scoliosis.

Authors:  Federico Canavese; Marie Rousset; Benoit Le Gledic; Antoine Samba; Alain Dimeglio
Journal:  World J Orthop       Date:  2014-04-18

2.  The Impact of Spinal Fusion on Hip Displacement in Cerebral Palsy.

Authors:  Mutlu Cobanoglu; Brian Po-Jung Chen; Lucio Perotti; Kenneth Rogers; Freeman Miller
Journal:  Indian J Orthop       Date:  2020-10-09       Impact factor: 1.251

3.  Simultaneous progression patterns of scoliosis, pelvic obliquity, and hip subluxation/dislocation in non-ambulatory neuromuscular patients: an approach to deformity documentation.

Authors:  Janki Patel; Frederic Shapiro
Journal:  J Child Orthop       Date:  2015-09-30       Impact factor: 1.548

Review 4.  Cerebral palsy with dislocated hip and scoliosis: what to deal with first?

Authors:  Ilkka J Helenius; Elke Viehweger; Rene M Castelein
Journal:  J Child Orthop       Date:  2020-02-01       Impact factor: 1.548

5.  Point Prevalence and Associated Factors of Hip Displacement in Pediatric Patients With Mitochondrial Disease.

Authors:  Sungmin Kim; Young-Mock Lee; Kun-Bo Park; Minsu Lee; Hoon Park
Journal:  Front Pediatr       Date:  2021-11-04       Impact factor: 3.418

6.  Progression of Hip Displacement during Radiographic Surveillance in Patients with Cerebral Palsy.

Authors:  Jae Young Park; Young Choi; Byung Chae Cho; Sang Young Moon; Chin Youb Chung; Kyoung Min Lee; Ki Hyuk Sung; Soon-Sun Kwon; Moon Seok Park
Journal:  J Korean Med Sci       Date:  2016-05-19       Impact factor: 2.153

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.